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Edited by Takashi GojoboriAbstract An NADH-dependent trans-2-enoyl-CoA reductase
(EC1.1.1.36) from the Gram negative spirochete Treponema
denticola was identiﬁed, expressed and biochemically character-
ized. The recombinant protein is a monomeric enzyme with a
molecular mass of 44 kDa with a speciﬁc activity of
43 ± 4.8 U/mg (lmol mg1 min1) and Km value of 2.7 lM for
crotonoyl-CoA. This NADH-dependent trans-2-enoyl-CoA
reductase represents the ﬁrst enzymatically characterized mem-
ber of a prokaryotic protein family involved in a fatty acid syn-
thesis pathway that is distinct from the familiar fatty acid
synthase system.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Treponema denticola is a spirochete that is commonly found
in the human oral cavity and is responsible for the pathogen-
esis of human periodontal diseases and acute necrotizing ulcer-
ative gingivitis [1,2], which results from the inﬂammatory
response of the host to the presence of subgingival plaque bac-
teria [3]. T. denticola is a facultative anaerobe, growing in par-
tially aerobic or anaerobic environments [4], that typically
produces lactate, succinate, and acetate as major end products.
Whereas T. denticola is closely related to the syphilis-causing
obligate human pathogen Treponema pallidum sub. pallidum,
their genomes show distinct metabolic diﬀerences due to the
greater biosynthetic capabilities of T. denticola [5]. The T. den-
ticola genome encodes 2786 proteins, of which 352 are cur-
rently annotated as unidentiﬁed open reading frames [5].
TER is an enzyme involved in the mitochondrial fatty acid
synthesis with a net gain of ATP in the absence of oxygen.
Recently, Hoﬀmeister et al. characterized a novel trans-2-en-
oyl-CoA reductase (TER; EC1.3.1.44) from Euglena gracilis [6]
that catalyzes the reduction of enoyl-CoA to acyl-CoA in the
wax ester fermentation pathway of the facultatively anaerobic
E. gracilis mitochondrion [6–9]. Euglena TER identiﬁed a new
family of enzymes that is widely distributed among prokary-
otic genomes, but without functionally characterized prokary-
otic homologues. Euglena TER showed sequence similarity to*Corresponding author. Fax: +49 211 811 3554.
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doi:10.1016/j.febslet.2007.03.013T. denticola open reading frame TDE0597, annotated, like all
other prokaryotic members of the family, with unknown func-
tion. Members of this protein family in prokaryotes are often
organized in gene cluster that suggest involvement in fatty acid
or related synthesis operating with CoA esters instead of acyl-
carrier-protein (ACP)-esters [6]. The function of prokaryotic
TER homologues deﬁned by the Euglena enzyme has not been
investigated so far. Here we report cloning, heterologous
expression and biochemical characterization of the T. denticola
trans-2-enoyl-CoA reductase, thereby assigning a function to a
member of this previously uncharacterized prokaryotic protein
family.2. Materials and methods
2.1. Cloning and heterologous expression of TdenTER
A freeze dried genomic DNA sample of T. denticola ATCC 35405
was kindly provided by Prof. H.F. Jenkinson (University of Bristol,
UK). PCR was performed, after initial denaturation for 10 min at
98 C, 30 cycles with 94 C for 15 s, 64 C for 30 s and 72 C for
90 s, ﬁnal extension at 72 C for 7 min in 20 mM Tris–HCl pH 8.0,
50 mM KCl, 0.5 mM betaine, 1.5 mM magnesium sulfate, 0.1 lM of
each dNTP, 1 mM of each primer, 1 unit of Triple Master polymerase
(Eppendorf), and 50–100 ng of DNA sample of T. denticola ATCC
35405 as template. A 1194-bp fragment [GenBank Accession No.
AE017248] was ampliﬁed with the following primers: Tden1Nde for,
5 0-TATACATATGATTGTAAAACCAATGGTTAGG-3 0; Tden1Bgl
for, 5 0-TATAGATCTTATGATTGTAAAACCAATGGTTAG-30;
and Tden1Xho rev, 5 0-CTCGAGTTAAATCCTGTCGAACCTTTC-
TACC-3 0 to introduce 5 0-NdeI, respectively, 5 0-BglII and 3 0-XhoI
restriction sites. The ampliﬁcation products were cloned into pET28a
or pET32a vectors (Novagen) which provide N-terminal His-tag fusion
proteins. For expression, E. coli strain BL21(DE3) (Novagen) was
used. Expression was induced by addition of 0.4 mM isopropyl 1-
thio-b-D-galactopyranoside (IPTG) at 37 C for 4 h. Expressed protein
was puriﬁed by aﬃnity chromatography using nickel–nitrilotriacetic
acid (Ni–NTA) agarose, eluted as recommended by the manufacturer
(Qiagen, Germany) and diluted with 70% glycerine to a ﬁnal concen-
tration of 0.5 lg/ll.
2.2. Enzyme assay
The assay was performed as described [6]. The standard assay mix-
ture contained potassium phosphate buﬀer pH 6.2, 0.4 mM NADH,
2 lM FAD and 500 lM crotonoyl-CoA (Sigma). The reaction mixture
was preincubated for 10 min at 30 C before addition of the substrate.
Activity was determined on a GENios microplate reader (Tecan
Instruments) by measuring decrease of absorbance at 340 nm. Kinetic
parameters of TdenTER were determined using substrate concentra-
tions from 0.1 to 1.5 mM of crotonoyl-CoA (trans-2-butenoyl-CoA,
Sigma) for determination of Km value. The standard concentration
of 500 lM crotonoyl-CoA was used to determine the Km value for
NADH. Triclosan (2,4,4 0-trichloro-2 0-hydroxydiphenylether, Irgasan,
Sigma) and Isoniazid (Sigma) were added to the assay mixture to ﬁnal
concentrations from 5 to 1000 lM. A stock solution of triclosan wasblished by Elsevier B.V. All rights reserved.
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in control assay to check possible inhibitory eﬀects on the enzymatic
activity.
2.3. Phylogenetic analysis
TER homologues were retrieved from GenBank and aligned with
ClustalW [10]. NeighborNet graph was constructed and visualized with
Splitstree [11]. The analysis and the comparison of the genomic region
surrounding TdenTER and the TER homologues from sequenced gen-
omes was performed using the Region View Search of the CMR re-
source at TIGR (tigr.org/tdb/).3. Results and discussion
3.1. Expression and catalytic properties of TdenTER
The 1194-bp fragment from the gene sequence TDE0597
[GenBank Accession No. AE017248] of T. denticola ATCC
35405, hitherto annotated as a hypothetical reading frame,
was ampliﬁed by PCR, cloned into the expression vector
pET28a and transformed into E. coli BL21(DE3). The Tden-
TER ORF expressed in pET28a with BL21(DE3) resulted in
soluble (Fig. 1) and active protein. The expressed enzyme
showed NADH-dependent activity, but was not active when
NADPH was used as cofactor. This is in contrast to the Eugle-
na TER, which accepts both NADH and NADPH [6]. The
speciﬁc activity of TdenTER was determined as 43.4 ± 4.8 U/
mg (lmol mg1 min1) using crotonoyl-CoA as substrate,
10-fold higher than E. gracilis TER activity (3.9 U/mg, Table45 kDa
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Fig. 1. (A) Coomassie-stained 12% SDS–Page of the fractions after
Ni–NTA puriﬁcation and (B). Western blot analysis with immunode-
tection of the TdenTER ORF in pET28a expressed in BL21(DE).
Detection was carried out with anti-His antibodies (monoclonal mouse
IgG, Novagen). Anti-mouse secondary antibody horseradish peroxi-
dase conjugate from goat was used and the signal was visualised with
the ECL Western blotting Analysis System (Amersham Biosciences).
Lane 1: soluble bacterial fraction. Lanes 2–11: diﬀerent fractions after
Ni–NTA puriﬁcation. Lane 2: ﬂow-through pET28a; lane 3: ﬂow-
through pET28a-TdenTER; lane 4: ﬁrst wash pET28a; lanes 5 and 6:
ﬁrst and second wash pET28a-TdenTER; lane 7: ﬁrst elution pET28a;
lanes 8–11: respectively, ﬁrst, second, third and fourth elution pET28a-
TdenTER.1). In contrast to Euglena TER, TdenTER did not accept
trans-hexenoyl-CoA as a substrate. TdenTER also possesses
a much higher aﬃnity for crotonoyl-CoA (Km = 2.7 lM) than
Euglena TER (Table 1) and a lower substrate inhibition
(Ki = 0,198 lM for crotonoyl-CoA) using NADH as cofactor.
As also reported for the Euglena TER, no oxidizing activity
was detectable in TdenTER in the reverse reaction when butyr-
yl-CoA was used as substrate. Multiple alignment of the Tden-
TER amino acid sequence (Fig. 3) with its closest homologues
revealed the presence of a ﬁngerprint motif typical for short-
chain dehydrogenase/reductase enzyme family [12]. The N-ter-
minal part of the consensus sequence displayed the motif
G53XXXGXG59 characteristic for NAD(P)H binding site
(GXXXGXG) [11]. Similarly, the YX37K motif containing
tyrosine and lysine usually present in the catalytic center of this
enzyme family was also found in TdenTER at residues 241–
248 and 290–296 with the motif YX6K and YX5K, respectively
[13]. Additionally, a putative FAD binding site (GXGXXG) at
the C-terminal of the amino acid sequence was missing (Fig. 3)
[14]. Accordingly, addition of FAD in the enzyme assay (0–
10 lM) had no eﬀects on enzyme activity.
The activity of TdenTER was measured in the presence of
triclosan, an antibacterial agent, known to inhibit enoyl-
CoA/ACP reductase (fabI) in E. coli and other organisms
through the formation of a fabI-NAD+-triclosan ternary com-
plex [15,16]. However, TdenTER showed no inhibition by tri-
closan in a wide range of concentration (5–1000 lM) (data not
shown). Sequence analysis revealed the absence in TdenTER
of amino acids such as Leu100, Tyr146, Tyr156, Met159,
Ala196, Ala197 (fabI, E. coli numbering) which play a key role
in the fabI-NAD+-triclosan ternary complex [17]. Isoniazid, a
clinically used antituberculosis drug, was also added to the as-
say (5–1000 lM) with no eﬀects on TdenTER activity, as well.3.2. Metabolism of T. denticola
T. denticola possesses a genome considerably larger in size
than the genomes of other spirochaetes, possibly reﬂecting niche
adaptation in the oral bioﬁlm environment [5,18]. The genome
analysis revealed the existence of genes encoding enzymes for
important metabolic and biosynthetic pathways. The presence
of glycolysis, gluconeogenesis, and a pentose phosphate path-
way in T. denticola with the absence of tricarboxylic acid cycle
(TCA) and an electron transport chain (ETC) suggests that
ATP is generated mainly through sugar fermentation and sub-
strate level phosphorylation [5]. Additionally, T. denticola
seems to be able to perform a de novo fatty acid synthesis in
contrast to T. pallidum andBorrelia burgdorferi, which are com-
pletely dependent on the fatty acids present as substrates in the
culture medium [5,19,20]. Spirochetes like T. hyodysenteriae, T.
innocens and T. vincentii are able to produce short chain fatty
acid (SCFA) as result of pyruvate fermentation [21]. Acetate
and butyrate are, in those organisms, the main fermentation
products from pyruvate and are directly associated with ATP
production. In the butyrate pathway, the reduction from croto-
noyl-CoA to butyryl-CoA is catalyzed by an enoyl-reductase
(EC1.3.1.44) [22–24], that is, however distinct from TdenTER.
T. denticola, on the other hand, is able to ferment cysteine, ser-
ine, alanine, and glycine to acetate and smaller amounts of lac-
tate, succinate, formate and pyruvate. It is also able to ferment
glucose, but far less eﬃciently than amino acids, and butyrate is
present only in trace amounts [21–25].
Table 1
Speciﬁc activity, Km and Ki values for Treponema denticola and Euglena gracilis with diﬀerent cofactors and substrates
E. gracilis T. denticola
Km Km Ki
NADH Crotonoyl-CoA 68 lM 2.7 lM 0.198 lM
Hexenoyl-CoA 91 lM – –
NADPH Crotonoyl-CoA 109 lM – –
Hexenoyl-CoA 119 lM – –
Speciﬁc activity
NADH Crotonoyl-CoA 3.9 U/mg 43 ± 4.8 U/mg
Hexenoyl-CoA 1.4 ± 0.02 U/mg
NADPH Crotonoyl-CoA 0.7 ± 0.09 U/mg
Hexenoyl-CoA 0.4 ± 0.10 U/mg
Speciﬁc activities and the Km values for E. gracilis are obtained from Hoﬀmeister et al. [6].
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Fig. 2. NeighborNet graph of TdenTER homologous sequences. The scale bar at the lower right side indicates estimated substitutions per site.
Abbreviations are as follows: b and c, proteobacteria; bactero, bacteroides; entero, enterobacteria, spiro, spirochete.
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The phylogenetic distribution of TER homologues among
prokaryotes reveals no archaebacteria homologues and a prev-alence among b and c-proteobacteria (Fig. 2). It occurs in the
genome of just one Gram positive organism characterized so
far, Streptomyces avermitilis. The TER homologue SAV2368
Fig. 3. Multiple sequence alignment of TdenTER with hypothetical trans-2-enoyl-CoA reductases. (A) Represents the putative binding site for
NAD(P)H; (B and C) for the substrate and (D) for FAD. Organisms and accession numbers are given as follows: Treponema denticola AE017248;
Euglena gracilis Q5EU90; Flavobacterium johnsoniae ZP01243065; Cytophaga hutchinsonii YP677688; Polaribacter irgensii ZP01118954; Coxiella
burnetii ZP01298067. The protein sequences retrieved from GenBank were aligned with ClustalW [10].
1564 S. Tucci, W. Martin / FEBS Letters 581 (2007) 1561–1566[GenBank Accession No. AB070934] from the S. avermitilis
polyketide biosynthetic cluster 5 (pks5) was expressed in
E. coli and Saccharomyces cerevisiae, but the recombinant pro-
tein was insoluble and inactive with either crotonoyl-CoA and
trans-2-hexenoyl-CoA as substrate (data not shown).
Many proteobacteria, such as B. mallei ATCC 23344, B.
pseudomallei K96243, C. psychrerythraea34H, P. aeruginosaPAO1, and P. putida KT2440 perform polyhydroxyalcanoate
(PHA) biosynthesis. PHAs are a class of biodegradable polyes-
ters produced mostly under oxygen limitation as carbon and
energy reserve [26–28]. The most well-studied type of PHA is
poly-hydroxybutyrate (PHB), synthesized from acetyl-CoA
by a sequence of three reactions catalyzed by b-ketothiolase
(EC2.3.1.9), acetoacetyl-CoA reductase (EC1.1.1.36) and
Treponema denticola ATCC 35405TDE 0597TDE 0598TDE 0599TDE 0600TDE 0602 TDE 0601
TdenTER and TER homologues
PIN Protein
domain
malonyl-CoA ACP
transacylase
3-oxoacyl-(ACP)
reductase
3-oxoacyl-(ACP)
synthase III
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Phosphatase AcpA
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cytocrome c
peroxydase
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HlyD family secretion
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Putative transcription
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Pseudomonas aeruginosa PAO1PA 2950PA 2951
electron transfer
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acyl-CoA dehydrogenase acyl-CoA
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Fig. 4. Operon analysis of TdenTER and TER homologues through the CMR resource at TIGR. White arrows show TER homologues of
TdenTER, grey arrows indicate hypothetical reading frames and hatched arrows proteins with distinct functions.
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pathway the presence of TdenTER is not necessary as the
product of the ﬁrst reduction step, b-hydroxybutyryl-CoA, is
required for the synthesis of PHB. Treponema has not been re-
ported to synthesize PHAs and lack the fatty acid biosynthesis
pathway. T. denticola’s ability to synthesize fatty acids and the
position of the gene sequence encoding TdenTER on the
downstream of fatty acid biosynthesis as shown in Fig. 4 sug-
gest that this enzyme could be involved in a novel fatty acid
synthesis pathway, possibly similar to PHA biosynthesis and
possibly independent of malonyl-CoA as starter unit and oper-
ating with CoA rather than ACP esters. The use of acetyl-CoA
directly avoids ATP consumption at the malonyl-CoA activa-
tion step catalyzed by the acetyl-CoA carboxylase [30]. Based
upon their distribution among various gene clusters (Fig. 4),
the family of prokaryotic TER enzymes described here would
appear to belong to the more versatile and ﬂexible components
of metabolism, rather than to dedicated core pathways of en-
ergy metabolism in these organisms, in contrast to the situa-
tion in Euglena.
Finally, some herbicides, such as ﬂufenacet, have been
shown to inhibit the TER-dependent mitochondrial fatty acid
biosynthesis pathway in Euglena [31]. These appear to inhibit
the elongation step, which distinguishes Euglena’s mitochon-
drial fatty acid biosynthesis from the FAS-pathways in yeast
or plants [32]. The eﬀect of ﬂufenacet or structurally related
elongase-inhibitor herbicides on Treponema has not been re-
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